(Q28203967)

https://api.crossref.org/works/10.1034/J.1399-3062.1999.010204.X

Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.

21 April 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

The human cytomegalovirus genes and proteins required for DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recov

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Mutations in the cytomegalovirus UL97 gene associated with ganciclovir-resistant retinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Value of a ligase chain reaction assay for detection of ganciclovir resistance-related mutation 594 in UL97 gene of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021

Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010204.X

7 January 2021